Response to "On the reproducibility of quantitative susceptibility mapping and its potential as a clinical biomarker: A comment on Cogswell et al. 2021"

Petrice M. Cogswell, Heather J. Wiste, Stephen D. Weigand, Terry M. Therneau, Clifford R. Jack Jr.. Response to "On the reproducibility of quantitative susceptibility mapping and its potential as a clinical biomarker: A comment on Cogswell et al. 2021". NeuroImage, 251:118992, 2022. [doi]

No reviews for this publication, yet.